Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2012; 18(16): 1933-1939
Published online Apr 28, 2012. doi: 10.3748/wjg.v18.i16.1933
Published online Apr 28, 2012. doi: 10.3748/wjg.v18.i16.1933
Figure 4 The progression-free survival rate and time tended to be superior in group A’ (a solid line) than in group B (a dotted line) (3-, 6-, 12-, and 24 mo = 75.
0%, 75.0%, 25.0%, and 0% vs 63.2%, 42.1%, 15.8% and 0%, respectively, P = 0.192).
- Citation: Kirikoshi H, Yoneda M, Mawatari H, Fujita K, Imajo K, Kato S, Suzuki K, Kobayashi N, Kubota K, Maeda S, Nakajima A, Saito S. Is hepatic arterial infusion chemotherapy effective treatment for advanced hepatocellular carcinoma resistant to transarterial chemoembolization? World J Gastroenterol 2012; 18(16): 1933-1939
- URL: https://www.wjgnet.com/1007-9327/full/v18/i16/1933.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i16.1933